IP Verse

Diagnostic Test System For Specific, Sensitive And Reproducible Detection Of Circulating Nucleic Acids In Whole Blood - EP3358020

PATENT ANALYSIS

Patent Details

Grant Date
May 19, 2021
Company
BIODESIX, INC.
Oppositions

QIAGEN GMBH

More patents of Biodesix, Inc.

EP3358020

Want to monitor this patent?

Feel free to send us a message here and we will get back to you